間質幹細胞市場規模、佔有率及成長分析（依產品、來源、適應症、應用及地區分類）－2026-2033年產業預測

全球間間質幹細胞(MSC) 市場規模預計在 2024 年達到 40.5 億美元，從 2025 年的 45.6 億美元成長到 2033 年的 117.9 億美元，在預測期（2026-2033 年）內複合年成長率為 12.6%。

全球間間質幹細胞(MSC) 市場正經歷顯著成長，這主要得益於其在再生醫學、組織工程和免疫調節等領域公認的治療應用。 MSC 具有分化為骨細胞、軟骨細胞和脂肪細胞的能力，能夠促進受損組織的修復和再生，使其成為臨床研究的前沿領域。慢性疾病發生率的上升、對細胞療法需求的增加以及在整形外科、神經科、腫瘤科和皮膚科等領域應用範圍的擴大，都推動了這一成長。此外，幹細胞庫和生物製程技術的進步也促進了臨床試驗的核准，並支持了 MSC 的廣泛應用。儘管 MSC 的應用仍面臨倫理問題、規模化生產和監管障礙等挑戰，但生物技術公司、研究機構和醫療服務提供者之間的合作對於市場擴張至關重要。

全球間質幹細胞市場促進因素

心血管疾病、骨關節炎、自體免疫疾病和神經系統疾病等慢性疾病發生率的不斷上升，是全球間間質幹細胞（MSC）市場的主要驅動力。 MSC因其具有再生受損組織和調節免疫反應的能力，被視為治療這些健康挑戰的一種極具前景的治療方法。隨著受影響人數的增加以及對創新再生療法需求的成長，基於MSC的治療方法預計將顯著應用。這一趨勢凸顯了MSC在慢性病管理和再生醫學領域中發揮的重要作用，尤其是在亟需有效解決方案的領域。

限制全球間質幹細胞市場的因素

間質幹細胞療法研發和應用的高成本是限制市場成長的一大障礙。間質幹細胞的生產需要專門的實驗室、先進的設備和熟練的人員，以確保細胞的活力、純度和無菌性。此外，細胞分離、擴增和冷凍保存等過程耗費大量資源和時間。這種複雜性增加了治療成本，並給患者帶來挑戰，尤其是在醫療體係不發達的發展中地區。因此，儘管間質幹細胞具有明顯的治療優勢，但由於這些經濟障礙，其廣泛應用往往低於預期。

全球間質幹細胞（MSC）市場趨勢

全球間間質幹細胞(MSC) 市場正經歷著向再生醫學和個人化醫療的動態轉變，反映出人們對針對個別患者需求量身定做治療方法的日益成長的需求。 MSC 具有修復和再生受損組織的獨特能力，這推動了其在治療多種疾病方面的應用，包括肌肉骨骼疾病、心血管疾病、神經系統疾病和自體免疫疾病。調查方法和生產技術的進步正在提高基於 MSC治療方法的精準性和擴充性。此外，將預測模型和人工智慧應用於患者篩選和治療方案製定，正在推動臨床療效的改善和副作用的減少，從而開啟一個以患者獨特健康需求為優先的個人化治療方案的未來。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術評估
• 監管環境

全球間質幹細胞市場規模（依產品及複合年成長率分類）（2026-2033 年）

• 細胞和細胞株
• 試劑盒、培養基和試劑
• 其他

全球間質幹細胞市場規模（依來源及複合年成長率分類）（2026-2033 年）

• 骨髓間間質幹細胞
• 脂肪組織來源的間質幹細胞
• 臍帶/胎盤來源的間質幹細胞
• 其他

全球間質幹細胞市場規模（按適應症和複合年成長率分類）（2026-2033 年）

• 骨/軟骨修復
• 心血管疾病
• 發炎/免疫性疾病
• 肝病
• 癌症
• 移植物抗宿主疾病（GvHD）及其他適應症

全球間質幹細胞市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 疾病模型
• 藥物發現與開發
• 幹細胞庫
• 組織工程
• 毒理學研究

全球間間質幹細胞市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Thermo Fisher Scientific Inc.
• STEMCELL Technologies Inc.
• Merck KGaA
• Lonza Group Ltd.
• Cyagen Biosciences Inc.
• PromoCell GmbH
• Axol Bioscience Ltd.
• Cellcolabs Clinical Ltd.
• Cell Applications Inc.
• Mesoblast Ltd.
• Cynata Therapeutics
• Orgenesis Inc.
• Stempeutics Research Pvt. Ltd.
• BioRestorative Therapies
• ScienCell Research Laboratories Inc.
• Takara Bio Inc.
• Takara Bio Inc.
• BioTime Inc.
• PLURI Inc.
• Cell Tech Pharmed

結論與建議

Global Mesenchymal Stem Cells Market size was valued at USD 4.05 Billion in 2024 and is poised to grow from USD 4.56 Billion in 2025 to USD 11.79 Billion by 2033, growing at a CAGR of 12.6% during the forecast period (2026-2033).

The global mesenchymal stem cells (MSCs) market is witnessing significant growth driven by the recognition of their therapeutic applications in regenerative medicine, tissue engineering, and immunomodulation. With their ability to facilitate repair and regeneration of damaged tissues by differentiating into bone, cartilage, and fat cells, MSCs are at the forefront of clinical research. This growth is propelled by the rising incidence of chronic diseases, increasing demand for cell-based therapies, and expanded application areas in orthopedics, neurology, oncology, and dermatology. Furthermore, advancements in stem cell banking and bioprocessing technologies enhance clinical trial approvals, supporting widespread adoption. Collaborative efforts among biotech firms, research institutions, and healthcare providers are essential for market expansion, despite challenges related to ethical concerns, scaling, and regulatory hurdles in MSC applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mesenchymal Stem Cells market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mesenchymal Stem Cells Market Segments Analysis

Global Mesenchymal Stem Cells Market is segmented by Product, Source, Indication, Application and region. Based on Product, the market is segmented into Cells & Cell Lines, Kits, Media & Reagents and Others. Based on Source, the market is segmented into Bone Marrow-derived MSCs, Adipose Tissue-derived MSCs, Umbilical Cord / Placental MSCs and Others. Based on Indication, the market is segmented into Bone & Cartilage Repair, Cardiovascular Diseases, Inflammatory & Immunological Diseases, Liver Diseases, Cancer and GvHD & Other Indications. Based on Application, the market is segmented into Disease Modeling, Drug Discovery & Development, Stem Cell Banking, Tissue Engineering and Toxicology Studies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mesenchymal Stem Cells Market

The increasing incidence of chronic conditions like cardiovascular issues, osteoarthritis, autoimmune disorders, and neurological diseases significantly fuels the global mesenchymal stem cells (MSCs) market. MSCs possess the ability to regenerate damaged tissues and influence the immune response, making them a promising therapeutic avenue for these health challenges. As the number of affected individuals rises and the demand for innovative regenerative treatments escalates, the adoption of MSC-based therapies is poised for substantial growth. This trend highlights the critical role of MSCs in addressing the urgent need for effective solutions in the realm of chronic disease management and regeneration.

Restraints in the Global Mesenchymal Stem Cells Market

The high costs associated with the development and administration of mesenchymal stem cell therapies significantly hinder market growth. Producing MSCs demands specialized laboratories, advanced equipment, and a skilled workforce to ensure the viability, purity, and sterility of the cells. Furthermore, the processes involved in cell isolation, expansion, and cryopreservation are resource-intensive and time-consuming. This complexity leads to elevated treatment expenses, posing a challenge for patients, particularly in developing regions where healthcare reimbursement may be lacking. Consequently, despite the evident therapeutic advantages of MSCs, their widespread adoption often lags behind expectations due to these financial barriers.

Market Trends of the Global Mesenchymal Stem Cells Market

The Global Mesenchymal Stem Cells (MSCs) market is experiencing a dynamic shift towards regenerative and personalized medicine, reflecting a growing preference for therapies tailored to individual patient needs. The intrinsic capabilities of MSCs in repairing and regenerating damaged tissues are driving their increased application in treating a range of conditions, including musculoskeletal, cardiovascular, neurological, and autoimmune disorders. Advances in research methodologies and manufacturing techniques are enhancing the precision and scalability of MSC-based therapies. Furthermore, the integration of predictive modeling and artificial intelligence in patient selection and therapy planning is fostering improved clinical outcomes and reduced side effects, heralding a future characterized by customized treatment approaches that prioritize patient-specific health needs.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Mesenchymal Stem Cells Market Size by Product & CAGR (2026-2033)

• Market Overview
• Cells & Cell Lines
• Kits, Media & Reagents
• Others

Global Mesenchymal Stem Cells Market Size by Source & CAGR (2026-2033)

• Market Overview
• Bone Marrow-derived MSCs
• Adipose Tissue-derived MSCs
• Umbilical Cord / Placental MSCs
• Others

Global Mesenchymal Stem Cells Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Bone & Cartilage Repair
• Cardiovascular Diseases
• Inflammatory & Immunological Diseases
• Liver Diseases
• Cancer
• GvHD & Other Indications

Global Mesenchymal Stem Cells Market Size by Application & CAGR (2026-2033)

• Market Overview
• Disease Modeling
• Drug Discovery & Development
• Stem Cell Banking
• Tissue Engineering
• Toxicology Studies

Global Mesenchymal Stem Cells Market Size & CAGR (2026-2033)

• North America (Product, Source, Indication, Application)
  • US
  • Canada
• Europe (Product, Source, Indication, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Source, Indication, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Source, Indication, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Source, Indication, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyagen Biosciences Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axol Bioscience Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellcolabs Clinical Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Applications Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mesoblast Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cynata Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orgenesis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stempeutics Research Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioRestorative Therapies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScienCell Research Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTime Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PLURI Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Tech Pharmed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations